“…In addition, the cost of treating epilepsy is also an economic burden that needs to be considered. 2 The study conducted by Jane Namusisi et al aimed to determine seizure control status and factors related to control among Children with Epilepsy (CWE) who received Anti-Seizure Medications (ASM). 1 The results found that threequarters of the correspondents had generalized onset seizures and the remainder had unrecognized focal and motor seizures.…”